Marshall Wace’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $341K | Sell |
4,000
-1,063,700
| -100% | -$94.8M | ﹤0.01% | 2606 |
|
|
2025
Q4 | $84.4M | Buy |
+1,067,700
| New | +$83.7M | 0.08% | 212 |
|
|
2025
Q2 | – | Sell |
-11,981
| Closed | -$1.12M | – | 2756 |
|
|
2025
Q1 | $1.12M | Sell |
11,981
-261,147
| -96% | -$23.4M | ﹤0.01% | 1733 |
|
|
2024
Q4 | $24.8M | Buy |
+273,128
| New | +$26.1M | 0.03% | 470 |
|
|
2024
Q3 | – | Sell |
-47,443
| Closed | -$4.6M | – | 2554 |
|
|
2024
Q2 | $4.6M | Sell |
47,443
-275,591
| -85% | -$25.4M | 0.01% | 1027 |
|
|
2024
Q1 | $29.1M | Sell |
323,034
-1,733,501
| -84% | -$147M | 0.04% | 386 |
|
|
2023
Q4 | $164M | Buy |
+2,056,535
| New | +$155M | 0.28% | 59 |
|
|
2023
Q1 | – | Sell |
-3,178
| Closed | -$250K | – | 2715 |
|
|
2022
Q4 | $250K | Sell |
3,178
-559,898
| -99% | -$42M | ﹤0.01% | 2625 |
|
|
2022
Q3 | $39.6M | Buy |
563,076
+498,378
| +770% | +$39.1M | 0.09% | 257 |
|
|
2022
Q2 | $5.19M | Sell |
64,698
-440,967
| -87% | -$34.5M | 0.01% | 1311 |
|
|
2022
Q1 | $38.3M | Buy |
505,665
+442,472
| +700% | +$35M | 0.07% | 297 |
|
|
2021
Q4 | $5.39M | Sell |
63,193
-255,124
| -80% | -$19.9M | 0.01% | 1299 |
|
|
2021
Q3 | $24.1M | Sell |
318,317
-160,833
| -34% | -$12.8M | 0.1% | 218 |
|
|
2021
Q2 | $39M | Buy |
479,150
+246,492
| +106% | +$20.2M | 0.18% | 112 |
|
|
2021
Q1 | $18.3M | Buy |
+232,658
| New | +$18.2M | 0.08% | 243 |
|
|
2020
Q4 | – | Sell |
-6,984
| Closed | -$539K | – | 1910 |
|
|
2020
Q3 | $539K | Sell |
6,984
-75,536
| -92% | -$5.76M | ﹤0.01% | 1223 |
|
|
2020
Q2 | $6.04M | Buy |
82,520
+80,434
| +3,856% | +$5.71M | 0.04% | 415 |
|
|
2020
Q1 | $138K | Sell |
2,086
-97,914
| -98% | -$6.91M | ﹤0.01% | 1262 |
|
|
2019
Q4 | $6.88M | Buy |
+100,000
| New | +$6.82M | 0.05% | 417 |
|
|
2019
Q2 | – | Sell |
-342,950
| Closed | -$23.5M | – | 1412 |
|
|
2019
Q1 | $23.5M | Buy |
342,950
+296,264
| +635% | +$19.1M | 0.22% | 92 |
|
|
2018
Q4 | $2.78M | Buy |
46,686
+284
| +0.6% | +$17.8K | 0.03% | 647 |
|
|
2018
Q3 | $3.11M | Sell |
46,402
-69,481
| -60% | -$4.63M | 0.03% | 570 |
|
|
2018
Q2 | $7.51M | Sell |
115,883
-7,895
| -6% | -$516K | 0.11% | 220 |
|
|
2018
Q1 | $8.87M | Buy |
123,778
+136
| +0.1% | +$9.79K | 0.37% | 75 |
|
|
2017
Q4 | $9.33M | Sell |
123,642
-95,289
| -44% | -$6.96M | 0.39% | 58 |
|
|
2017
Q3 | $16M | Buy |
218,931
+123,116
| +128% | +$8.87M | 0.74% | 32 |
|
|
2017
Q2 | $7.09M | Buy |
95,815
+14,736
| +18% | +$1.09M | 0.31% | 64 |
|
|
2017
Q1 | $5.92M | Buy |
81,079
+23,706
| +41% | +$1.66M | 0.29% | 79 |
|
|
2016
Q4 | $3.75M | Sell |
57,373
-157,915
| -73% | -$10.8M | 0.02% | 532 |
|
|
2016
Q3 | $16M | Buy |
215,288
+62,974
| +41% | +$4.66M | 0.11% | 197 |
|
|
2016
Q2 | $11.2M | Sell |
152,314
-193,322
| -56% | -$13.8M | 0.09% | 233 |
|
|
2016
Q1 | $24.4M | Buy |
+345,636
| New | +$23M | 0.24% | 109 |
|
|
2015
Q3 | – | Sell |
-33,304
| Closed | -$2.18M | – | 930 |
|
|
2015
Q2 | $2.18M | Buy |
33,304
+14,229
| +75% | +$965K | 0.03% | 461 |
|
|
2015
Q1 | $1.32M | Buy |
19,075
+11,155
| +141% | +$771K | 0.02% | 529 |
|
|
2014
Q4 | $548K | Sell |
7,920
-163,868
| -95% | -$11.1M | 0.01% | 650 |
|
|
2014
Q3 | $11.2M | Sell |
171,788
-101,259
| -37% | -$6.68M | 0.16% | 169 |
|
|
2014
Q2 | $18.6M | Buy |
273,047
+260,633
| +2,100% | +$17.5M | 0.27% | 100 |
|
|
2014
Q1 | $805K | Buy |
+12,414
| New | +$782K | 0.01% | 519 |
|
Other funds holding CL
VCM
DAM
VPM
Marshall Wace's CL Position: Q1 2026 in Review
Marshall Wace reduced its Colgate-Palmolive (CL) stake by 100% in Q1 2026, selling an estimated $94.8M and leaving 4,000 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.
Marshall Wace first reported a position in CL in Q1 2014 and has held it in 38 quarters since. The position peaked at $164M in Q4 2023. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Marshall Wace held 4,000 shares of Colgate-Palmolive worth $341K as of Q1 2026.
- Marshall Wace sold 1,063,700 Colgate-Palmolive shares in Q1 2026, an estimated $94.8M.
- Colgate-Palmolive made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2606 holding.
- Marshall Wace first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 38 quarters since.
- Marshall Wace's Colgate-Palmolive position peaked at $164M in Q4 2023.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.